Treatment selection in a randomized clinical trial via covariate-specific treatment effect curves

Stat Methods Med Res. 2017 Feb;26(1):124-141. doi: 10.1177/0962280214541724. Epub 2016 Sep 30.

Abstract

For time-to-event data in a randomized clinical trial, we proposed two new methods for selecting an optimal treatment for a patient based on the covariate-specific treatment effect curve, which is used to represent the clinical utility of a predictive biomarker. To select an optimal treatment for a patient with a specific biomarker value, we proposed pointwise confidence intervals for each covariate-specific treatment effect curve and the difference between covariate-specific treatment effect curves of two treatments. Furthermore, to select an optimal treatment for a future biomarker-defined subpopulation of patients, we proposed confidence bands for each covariate-specific treatment effect curve and the difference between each pair of covariate-specific treatment effect curve over a fixed interval of biomarker values. We constructed the confidence bands based on a resampling technique. We also conducted simulation studies to evaluate finite-sample properties of the proposed estimation methods. Finally, we illustrated the application of the proposed method in a real-world data set.

Keywords: covariate-specific treatment effect curve; pointwise confidence interval; predictive biomarker; simultaneous confidence interval; time-to-event outcome; varying coefficient.

MeSH terms

  • Biomarkers
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / genetics
  • Confidence Intervals
  • Genes, myc / genetics
  • Humans
  • Randomized Controlled Trials as Topic / methods*

Substances

  • Biomarkers